These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 7251238

  • 1. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D, Molz KH, Staib AH, Rietbrock N.
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [Abstract] [Full Text] [Related]

  • 2. Absorption of sustained-release theophylline tablets.
    Fagerström PO, Heintz L.
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB, Guarnone E, Bartoli A, Ciardelli L, Piacentini P.
    Minerva Med; 1985 Mar 31; 76(13):641-5. PubMed ID: 3991030
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO, Mellstrand T, Svedmyr N.
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar 31; 19(3):131-8. PubMed ID: 7228455
    [Abstract] [Full Text] [Related]

  • 7. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU, Steinijans VW, Gabel H.
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov 31; 22(11):621-5. PubMed ID: 6500759
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R, Billing B.
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb 31; 21(2):69-72. PubMed ID: 6840927
    [Abstract] [Full Text] [Related]

  • 9. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T, Svedmyr N, Fagerström PO.
    Eur J Respir Dis Suppl; 1980 Feb 31; 109():54-60. PubMed ID: 6934088
    [Abstract] [Full Text] [Related]

  • 10. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH, van der Boon WJ, Schoenmaker R, Holtkamp A, Thürkow-Luikens AJ.
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep 31; 22(9):506-10. PubMed ID: 6500770
    [Abstract] [Full Text] [Related]

  • 11. The relation of product formulation to absorption of oral theophylline.
    Weinberger M, Hendeles L, Bighley L.
    N Engl J Med; 1978 Oct 19; 299(16):852-7. PubMed ID: 692577
    [Abstract] [Full Text] [Related]

  • 12. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M, Rondanelli R, Vidale E, Cristiani D.
    Int J Clin Pharmacol Ther Toxicol; 1983 May 19; 21(5):245-51. PubMed ID: 6862729
    [Abstract] [Full Text] [Related]

  • 13. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
    Bochsler HP, Meyer UA.
    Schweiz Med Wochenschr; 1982 Nov 20; 112(47):1702-10. PubMed ID: 7178872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP, Drost RH, Kreukniet J, Maes RA.
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug 20; 22(8):423-9. PubMed ID: 6490224
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M, Retzow A, Vens-Cappell B.
    Int J Clin Pharmacol Ther; 1999 Feb 20; 37(2):100-8. PubMed ID: 10082174
    [Abstract] [Full Text] [Related]

  • 17. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K, Hasegawa T, Ogura Y, Yamaki K, Suzuki R, Satake T, Imaeda N, Mizukami Y.
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct 20; 25(10):530-5. PubMed ID: 3429057
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Absolute bioavailability of theophylline (Euphylline)].
    Somogyi A, Gugler R.
    Fortschr Med; 1980 Nov 20; 98(43):1707-10. PubMed ID: 7450653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.